Check out the 13-slide deck health startup OneLeaf used to raise $5.1 million to expand its personalized self-hypnosis programs across the US
This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now.
- Paris-based OneLeaf has raised $5.1 million from French venture capital firm Frst.
- Its self-hypnosis program aims to help users with wellness challenges, such as weight management and sleep deprivation.
- Check out the 13-slide deck used to raise the fresh funds.
Startup founder Eliott Cohen-Skalli had been struggling with quitting smoking. After trying multiple different treatments, he discovered that hypnosis can help with tobacco addiction — in addition to other health problems such as sleep, stress, chronic pain, and weight loss. And through hypnotherapy, he was able to successfully kick his smoking habit.
That’s what inspired him to found wellness startup OneLeaf, which just raised $5.1 million to grow its self-hypnosis program across the US. Cohen-Skalli previously founded French luxury home rental startup Le Collectionist.
Amid a dip in investment for wellness startups globally, OneLeaf, which was founded in 2022, cinched funding from French venture capital firm Frst, which has previously backed activist investment platform Tulipshare and medical startup Owkin. Additional participation came from French VC firms Kima Ventures and Raise Ventures.
The Paris-based startup offers users a self-hypnosis tool for to help them face health challenges such as smoking, weight management, and anxiety. Its audio-based program was designed with the help of experts such as hypnotherapy specialist Dr. Laurent Taton, and is tailored to the user’s lifestyle.
OneLeaf’s program to quit smoking spans 21 days and offers 15-20 minute audio clips with guided self-hypnosis prompts.
While other startups like Octopus Ventures-backed Quit Genius and Vice Venture’s backed Lucy help people quit smoking, most companies on the market offer products like gum, patches, and breath sensors. Focusing on self-hypnosis as a treatment option makes OneLeaf unique, Cohen-Skalli said, and also positions the startup to grow into other wellness industries.
“By entering an industry right from the start, we don’t have many competitors doing it the way we are,” he said. “The best entry point for investors is to enter a small industry that’s growing and then make sure we are at the forefront.”